LENZ LENZ Therapeutics, Inc.: institutional ownership and insider trading
148 funds reported holding $220M of LENZ Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $9.04M, with 26 new positions and 26 funds selling out; over the last 12 months insiders bought $655K and sold $261K on the open market; over its last four quarters it reported revenue of $21.5M and net income of −$126M.
LENZ revenue and earnings
- Quarter ended Jun 30, 2026: revenue $5.49M, net income −$31.9M, EPS -1.02
- Quarter ended Mar 31, 2026: revenue $1.90M, net income −$41.5M, EPS -1.32
- Quarter ended Dec 31, 2025: revenue $1.59M, net income −$35.9M, EPS -1.20
- Quarter ended Sep 30, 2025: revenue $12.5M, net income −$16.7M, EPS -0.59
Famous investors holding LENZ
- Izzy Englander (Millennium Management): $8.57M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.30M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.62M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $401K, 0.0% of the portfolio
Largest institutional holders of LENZ
- RA CAPITAL MANAGEMENT, L.P. — $23.7M
- VANGUARD GROUP INC — $21.1M
- Alpha Wave Global, LP — $20.5M
- FMR LLC — $20.2M
- Versant Venture Management, LLC — $15.1M
- BlackRock, Inc. (BLK) — $13.0M
- Squarepoint Ops LLC — $9.92M
- Aberdeen Group plc — $8.79M
- MILLENNIUM MANAGEMENT LLC — $8.57M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.24M
Recent LENZ insider trades
- Mar 27, 2026: Chevallard Daniel R. bought 7,500 shares ($64.3K)
- Mar 27, 2026: Schimmelpennink Evert B. bought 28,089 shares ($251K)
- Mar 27, 2026: George Jeffrey P. bought 5,592 shares ($49.9K)
- Nov 17, 2025: Olsson Shawn sold 10,000 shares ($261K)
5%+ owners
- BlackRock, Inc.: 5.8% (Schedule 13G, filed Apr 27, 2026)
- FMR LLC: 5.7% (Schedule 13G/A, filed Sep 8, 2026)
- Squarepoint Ops LLC: 5.1% (Schedule 13G, filed Apr 8, 2026)
Who owns the most LENZ stock?
The largest institutional holders of LENZ Therapeutics, Inc. in the latest 13F filings are RA CAPITAL MANAGEMENT, L.P. ($23.7M), VANGUARD GROUP INC ($21.1M), Alpha Wave Global, LP ($20.5M).
Are insiders buying or selling LENZ?
Over the last 12 months insiders bought $655K and sold $261K of LENZ Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own LENZ?
Izzy Englander, Ken Griffin, Two Sigma, Renaissance Technologies.
What was LENZ's revenue last quarter?
LENZ Therapeutics, Inc. reported revenue of $5.49M for the quarter ended June 30, 2026, with net income of −$31.9M.